Skip to main content
No access
Articles
Published Online: 1 August 2024

Psychiatric Diagnoses in Parents and Psychiatric, Behavioral, and Psychosocial Outcomes in Their Offspring: A Swedish Population-Based Register Study

Publication: American Journal of Psychiatry

Abstract

Objective:

Associations were examined between six psychiatric diagnoses in parents and a broad range of psychiatric and nonpsychiatric outcomes in their offspring.

Methods:

All individuals born in Sweden between 1970 and 2000 were linked to their biological parents (N=3,286,293) through Swedish national registers. A matched cohort design, with stratified Cox regression and conditional logistic regression analyses, was used examine associations between six psychiatric diagnoses in the parents and 32 outcomes in their offspring. All children, including those exposed and those not exposed to parents with psychiatric diagnoses, were followed from their date of birth to the date of emigration from Sweden, death, or December 31, 2013, when the offspring were 14–44 years old.

Results:

In terms of absolute risk, most children who had parents with psychiatric diagnoses were not diagnosed in specialist care themselves, and the proportion of offspring having any of the 16 types of psychiatric conditions ranged from 22.17% (of offspring exposed to parental depression) to 25.05% (of offspring exposed to parental drug-related disorder) at the end of follow-up. Nevertheless, in terms of relative risk, exposure to any of the six parental psychiatric diagnoses increased probabilities of the 32 outcomes among the offspring, with hazard ratios that ranged from 1.03 to 8.46 for time-to-event outcomes and odds ratios that ranged from 1.29 to 3.36 for binary outcomes. Some specificities were observed for parental diagnoses of psychosis and substance-related disorders, which more strongly predicted psychotic-like and externalizing-related outcomes, respectively, in the offspring.

Conclusions:

The intergenerational transmission of parental psychiatric conditions appeared largely transdiagnostic and extended to nonpsychiatric outcomes in offspring. Given the broad spectrum of associations with the outcomes, service providers (e.g., psychiatrists, teachers, and social workers) should consider clients’ broader psychiatric family history when predicting prognosis and planning interventions or treatment.

Get full access to this article

View all available purchase options and get full access to this article.

Supplementary Material

File (appi.ajp.20230353.ds001.pdf)

Information & Authors

Information

Published In

Go to American Journal of Psychiatry
Go to American Journal of Psychiatry
American Journal of Psychiatry
Pages: 761 - 773

History

Received: 2 May 2023
Revision received: 13 September 2023
Revision received: 24 October 2023
Revision received: 22 November 2023
Accepted: 20 December 2023
Published online: 1 August 2024
Published in print: August 01, 2024

Keywords

  1. Development
  2. Epidemiology
  3. Intergenerational Transmission
  4. Offspring Psychiatric and Nonpsychiatric Outcomes
  5. Parent Psychopathology
  6. Register Study

Authors

Affiliations

Mengping Zhou, M.Sc. [email protected]
Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm (Zhou, Lageborn, Sjölander, Larsson, Landén, Lichtenstein, Pettersson); Department of Psychological and Brain Sciences, Indiana University, Bloomington (D’Onofrio); Institute of Neuroscience and Physiology, Sahlgrenska Academy at Gothenburg University, Gothenburg, Sweden (Landén).
Christine Takami Lageborn, Ph.D.
Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm (Zhou, Lageborn, Sjölander, Larsson, Landén, Lichtenstein, Pettersson); Department of Psychological and Brain Sciences, Indiana University, Bloomington (D’Onofrio); Institute of Neuroscience and Physiology, Sahlgrenska Academy at Gothenburg University, Gothenburg, Sweden (Landén).
Arvid Sjölander, Ph.D.
Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm (Zhou, Lageborn, Sjölander, Larsson, Landén, Lichtenstein, Pettersson); Department of Psychological and Brain Sciences, Indiana University, Bloomington (D’Onofrio); Institute of Neuroscience and Physiology, Sahlgrenska Academy at Gothenburg University, Gothenburg, Sweden (Landén).
Henrik Larsson, Ph.D.
Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm (Zhou, Lageborn, Sjölander, Larsson, Landén, Lichtenstein, Pettersson); Department of Psychological and Brain Sciences, Indiana University, Bloomington (D’Onofrio); Institute of Neuroscience and Physiology, Sahlgrenska Academy at Gothenburg University, Gothenburg, Sweden (Landén).
Brian D’Onofrio, Ph.D.
Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm (Zhou, Lageborn, Sjölander, Larsson, Landén, Lichtenstein, Pettersson); Department of Psychological and Brain Sciences, Indiana University, Bloomington (D’Onofrio); Institute of Neuroscience and Physiology, Sahlgrenska Academy at Gothenburg University, Gothenburg, Sweden (Landén).
Mikael Landén, Ph.D.
Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm (Zhou, Lageborn, Sjölander, Larsson, Landén, Lichtenstein, Pettersson); Department of Psychological and Brain Sciences, Indiana University, Bloomington (D’Onofrio); Institute of Neuroscience and Physiology, Sahlgrenska Academy at Gothenburg University, Gothenburg, Sweden (Landén).
Paul Lichtenstein, Ph.D.
Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm (Zhou, Lageborn, Sjölander, Larsson, Landén, Lichtenstein, Pettersson); Department of Psychological and Brain Sciences, Indiana University, Bloomington (D’Onofrio); Institute of Neuroscience and Physiology, Sahlgrenska Academy at Gothenburg University, Gothenburg, Sweden (Landén).
Erik Pettersson, Ph.D.
Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm (Zhou, Lageborn, Sjölander, Larsson, Landén, Lichtenstein, Pettersson); Department of Psychological and Brain Sciences, Indiana University, Bloomington (D’Onofrio); Institute of Neuroscience and Physiology, Sahlgrenska Academy at Gothenburg University, Gothenburg, Sweden (Landén).

Notes

Send correspondence to Ms. Zhou ([email protected]).

Competing Interests

Dr. Larsson has received grants from Shire Pharmaceuticals; he has received personal fees from and served as a speaker for Evolan Pharma AB, Medice, and Shire/Takeda Pharmaceuticals; he has received sponsorship for a conference on attention deficit hyperactivity disorder from Evolan Pharma AB and Shire/Takeda Pharmaceuticals; and he is the editor-in-chief of JCPP Advances. The other authors report no financial relationships with commercial interests.

Funding Information

Dr. Lageborn was supported by the Karolinska Institutet Clinical Scientist Trainee Program, the Forskar-AT, and Bror Gadelius Minnesfond. Dr. Pettersson was supported by the Swedish Research Council for Health, Working Life and Welfare (grant 2023-00402), the Swedish Research Council (grant 2017-01358), the Svenska Läkaresällskapet (grant SLS-943288), the Stiftelsen Söderström-Königska (grant SLS-968742), and the Åke Wiberg Foundation.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

There are no citations for this item

View Options

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - American Journal of Psychiatry

PPV Articles - American Journal of Psychiatry

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

View options

PDF/ePub

View PDF/ePub

Full Text

View Full Text

Media

Figures

Other

Tables

Share

Share

Share article link

Share